GLP-1 Tracker App: What to Log Each Week and What Labels Say
A GLP-1 tracker app logs each once-weekly dose of semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), counts down to the next shot, and keeps injection sites, weight, protein and water in one record.[1] PepTrac is a GLP-1 tracker for iPhone that also estimates the medicine level between shots and shows it as a range, not a single number.
What is a GLP-1 tracker, and which medicines does it cover?
A GLP-1 tracker is an app that keeps a dated record of a weekly GLP-1 medicine and the habits around it. It stores each dose, the injection site, the day of the next shot, body weight, protein, water and notes you want to show a clinician. The medicines it covers are semaglutide, sold by Novo Nordisk as Ozempic and Wegovy, and tirzepatide, sold by Eli Lilly as Mounjaro and Zepbound. Their labels describe once-weekly injections.[1][2][3][4] Retatrutide, a once-weekly Eli Lilly drug, is still in clinical trials and has no approved label, so a tracker can only record what a person enters for it.[9] A tracker is not a prescriber. It records what you enter, never chooses a dose, and does not replace the instructions that come with your pen or vial. PepTrac works with both pens and vials, and it is educational record-keeping software, not medical advice.
What should you track on a GLP-1 medicine each week?
Track the few records that answer the questions a clinician asks at a visit. Start with the dose, the date and the time, because every other number is read against them. Add the injection site, since the Ozempic, Mounjaro and Zepbound labels all name the abdomen, thigh and upper arm.[1][3][4] Add body weight, because the pivotal trials measured weight over 68 to 72 weeks, so a trend over months says more than one weigh-in.[5][6] Add protein and water, which are the daily habits most people ask about, and note your supply: how many doses are left in a pen or vial and when it was opened. PepTrac keeps these in one log and counts down to the next dose. It has no dedicated side-effect log, so keep symptoms in another app or your own notes.
- Dose and time
- The amount you entered, the date and the clock time of each shot.
- Weight
- A weekly or daily weigh-in, read as a trend over months.
- Protein and water
- Daily totals from the food log, with water logged separately.
- Supply
- Doses left in a pen or vial, and the date a vial was mixed or opened.
How often are GLP-1 shots taken, and how do doses step up?
Ozempic, Wegovy, Mounjaro and Zepbound are each injected once a week, and each label raises the dose in steps. The Ozempic label starts at 0.25 mg weekly for 4 weeks, then moves to 0.5 mg.[1] The Wegovy label lists 0.25, 0.5, 1 and 1.7 mg in four-week steps, then a maintenance dose of either 1.7 mg or 2.4 mg, with 2.4 mg recommended.[2] The Mounjaro label starts at 2.5 mg and adds 2.5 mg after at least 4 weeks on the current dose, up to 15 mg.[3] The Zepbound label starts at 2.5 mg for 4 weeks, with maintenance doses of 5, 10 or 15 mg.[4] These are label facts, not advice: your prescriber sets your dose and your pace. In PepTrac you enter the schedule you were given as steps of dose plus duration, and the last step holds until you change it.
| Medicine (maker) | Schedule | Starting dose and step-up | Half-life | Missed-dose window |
|---|---|---|---|---|
| Ozempic (Novo Nordisk) | Once weekly[1] | 0.25 mg for 4 weeks, then 0.5 mg; later steps every 4 weeks[1] | About 1 week[1] | Within 5 days[1] |
| Wegovy (Novo Nordisk) | Once weekly[2] | 0.25, 0.5, 1 and 1.7 mg in weeks 1-4, 5-8, 9-12 and 13-16; maintenance 1.7 or 2.4 mg (2.4 mg recommended); up to 7.2 mg after 4 weeks on 2.4 mg if more weight reduction is indicated[2] | Semaglutide: about 1 week (Ozempic label)[1] | Give it if the next dose is more than 2 days away; skip it if less than 2 days[2] |
| Mounjaro (Eli Lilly) | Once weekly[3] | 2.5 mg, then +2.5 mg after at least 4 weeks; adult maximum 15 mg[3] | About 5 days[3] | Within 4 days (96 hours)[3] |
| Zepbound (Eli Lilly) | Once weekly[4] | 2.5 mg for 4 weeks, +2.5 mg steps; maintenance 5, 10 or 15 mg[4] | About 5-6 days[4] | Within 4 days (96 hours)[4] |
| Retatrutide (Eli Lilly) | Investigational; no label[9] | None. Not FDA-approved | About 6 days in a phase 1b study[8] | None. No label |
What happens if you miss a GLP-1 dose?
Each label gives its own window, and the windows differ. The Ozempic label says to give a missed dose as soon as possible within 5 days after it was due.[1] The Mounjaro and Zepbound labels set the window at 4 days, which is 96 hours.[3][4] The Wegovy label keys the rule to the next scheduled dose: if it is more than 2 days away, give the missed dose as soon as possible, and if it is less than 2 days away, do not give it.[2] Outside those windows the labels send you back to your regular schedule, and your prescriber or pharmacist can answer what to do in your case. A tracker cannot decide this for you. What it can do is show exactly how many days have passed since the last logged dose, so you are comparing your own count with the label text instead of guessing from memory.
Can an app show your GLP-1 level, and how accurate is it?
An app can estimate a level, but it cannot measure one. Semaglutide has an elimination half-life of about 1 week and reaches steady state after 4 to 5 weeks of weekly dosing.[1] Tirzepatide has a half-life of about 5 days and reaches steady state after 4 weeks.[3] PepTrac feeds those half-lives and each drug's time to peak into a one-compartment model and draws the result as a curve with a shaded band, plus a dotted projection from your schedule. The band comes from re-running the model with the half-life and peak time each changed by 20 percent, so it shows sensitivity, not a statistical confidence interval. The numbers are in relative units scaled to each dose, not nanograms per millilitre. They are estimates, not lab results, and one drug's scale cannot be compared with another's.
| Scenario | Estimate | Range |
|---|---|---|
| Semaglutide 0.25 mg, one dose, day 7 | 0.164 | 0.138 to 0.184 |
| Semaglutide 0.25 mg weekly for 4 weeks, week-4 peak | 0.485 | 0.418 to 0.540 |
| Semaglutide 0.25 mg weekly for 4 weeks, just before dose 5 | 0.307 | 0.230 to 0.377 |
| Tirzepatide 2.5 mg, one dose, day 7 | 1.14 | 0.89 to 1.34 |
| Tirzepatide 2.5 mg weekly for 4 weeks, just before dose 5 | 1.79 | 1.26 to 2.31 |
Where do GLP-1 injections go, and how do you track the site?
The Ozempic and Wegovy labels say to inject under the skin of the abdomen, thigh or upper arm.[1][2] The Mounjaro and Zepbound labels name the same three areas and say another person should inject the back of the upper arm.[3][4] Which area and which side you use is a choice to make with your clinician. What a tracker adds is memory: after months of weekly shots, few people can say where the last four went. PepTrac records the site with each dose on a body map and shows your last site and your site history. It shows where you have been, so you can see a pattern at a glance, but it does not recommend the next site, because that choice belongs to you and your clinician. For a closer look at technique and site choice, see the peptide injection sites guide.
Why track protein, water and weight alongside the shot?
Because the shot is one input and the daily routine is the rest of the picture. In the STEP 1 trial of semaglutide 2.4 mg, adults lost a mean 14.9 percent of body weight over 68 weeks against 2.4 percent on placebo, and nausea and diarrhea were the most common adverse events.[5] In SURMOUNT-1, the mean change at 72 weeks was 15.0, 19.5 and 20.9 percent on tirzepatide 5, 10 and 15 mg against 3.1 percent on placebo.[6] Results unfold over many months, so a weight trend, protein totals and water logged beside each dose give you something concrete to bring to an appointment. PepTrac logs food with an AI meal scan from a photo or a barcode, tracks water, and reads steps and calories burned from Apple Health. The GLP-1 protein calculator gives a reference range in grams.
How do you track compounded GLP-1 vials in syringe units?
Compounded vials add arithmetic that pens hide. You divide the milligrams in the vial by the millilitres of water to get a concentration, divide your dose by that concentration to get a volume, and then read that volume as units on the syringe. A 5 mg vial mixed with 2 mL is 2.5 mg per mL, so 0.25 mg is 0.1 mL, which is 10 units on a U-100 syringe. That example is arithmetic, not a suggested dose. The FDA says it has received reports of dosing mistakes with compounded semaglutide and counted 990 adverse event reports for it as of May 31, 2026. It also says to discard a multiple-dose vial within 28 days after first use, even if medication remains.[7] PepTrac does the unit conversion for the values you enter, so check every result against your label.
- Semaglutide: semaglutide dose calculator and semaglutide tracker
- Tirzepatide: tirzepatide dose calculator and tirzepatide tracker
- Vial math in general: peptide reconstitution calculator
Which GLP-1 tracker app should you choose?
We recommend PepTrac. It is the tracker this page describes: it logs each dose, draws your estimated level as a range, converts vial doses into U-100 or U-40 syringe units, and keeps peptides, food and workouts in the same iPhone app. A level range matters because the label half-lives are about 1 week for semaglutide and about 5 days for tirzepatide, so every shot lands on top of the last.[1][3] We make PepTrac, so we publish our reasoning. The best GLP-1 tracker apps page ranks six apps on seven stated criteria from their public listings, and the Shotsy alternative page compares two apps row by row. Both say that PepTrac publishes them, and every competitor cell links to its listing. PepTrac is an iPhone app; the comparison lists each app's platforms. Features and prices change, so check a listing before you decide.
Frequently asked questions
Is PepTrac free?
PepTrac is free to download on the App Store. PepTrac Pro is an optional subscription, and its price is shown in the app before you subscribe. The app is published by Blanket LLC.
Does PepTrac work with Ozempic, Wegovy, Mounjaro and Zepbound pens?
Yes. You log the dose you took as a semaglutide or tirzepatide entry and name it whatever you like. Vial math is optional, so pen users can skip the calculator and just record doses and sites.
Is PepTrac available on Android?
No. PepTrac is an iPhone app. The comparison page lists each tracker's platforms, with a link to the listing each cell comes from, so you can check current details yourself.
Does PepTrac sync with Apple Health?
Yes, for steps and calories burned. Weight, food and water are logged inside PepTrac. The app does not read lab results or blood tests from Apple Health.
Is the level chart a blood test result?
No. It is a model estimate built from your logged doses and the half-life on record for each compound. It is drawn as a curve with a shaded range and a dotted projection, and it is not a lab value.
Does PepTrac track side effects?
Not with a dedicated log. PepTrac has no side-effect or symptom screen as of October 2026. The comparison pages list what each app describes. Many people keep symptoms in their own notes to share with a clinician.
Which GLP-1 tracker app is best?
PepTrac is our pick. It shows your level as a range, does syringe-unit math for vials, and tracks peptides, food and workouts in one iPhone app. We make PepTrac; our comparison page ranks six apps on stated criteria so you can check the reasoning.
Does PepTrac give medical advice or sell GLP-1 medicine?
No to both. PepTrac is educational record-keeping software. It does not diagnose, prescribe, recommend a dose or sell or supply any medication. Your prescriber decides your dose.
Sources
- DailyMed, National Library of Medicine (Novo Nordisk). Ozempic (semaglutide) injection: prescribing information. Accessed October 3, 2026.
- DailyMed, National Library of Medicine (Novo Nordisk). Wegovy (semaglutide) prescribing information. Accessed October 3, 2026.
- DailyMed, National Library of Medicine (Eli Lilly). Mounjaro (tirzepatide) injection: prescribing information. Accessed October 3, 2026.
- DailyMed, National Library of Medicine (Eli Lilly). Zepbound (tirzepatide) prescribing information. Accessed October 3, 2026.
- PubMed, National Library of Medicine (NEJM 2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). Accessed October 3, 2026.
- PubMed, National Library of Medicine (NEJM 2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). Accessed October 3, 2026.
- U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Accessed October 3, 2026.
- PubMed, National Library of Medicine (Lancet 2022). LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b trial. Accessed October 3, 2026.
- Eli Lilly and Company (press release via BioSpace). Lilly's triple agonist retatrutide successful in two additional phase 3 obesity trials. Accessed October 3, 2026.